Ligne de temps
Béatrice Corre
Ingénieur(e) de Recherche
01 avr. 2024
publication
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes.
Lire plus25 mars 2024
news
New publication – Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
Lire plus15 août 2023
publication
A major role for CD4+ T cells in driving cytokine release syndrome during CAR T cell therapy.
Lire plus05 juin 2023
news
New publication – Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity
Lire plus29 mai 2023
publication
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity.
Lire plus17 févr. 2023
publication
Integration of intermittent calcium signals in T cells revealed by temporally patterned optogenetics.
Lire plus23 août 2022
publication
SPICE-Met: profiling and imaging energy metabolism at the single-cell level using a fluorescent reporter mouse.
Lire plus19 juil. 2022
publication
Spatiotemporal dynamics of calcium signals during neutrophil cluster formation.
Lire plus15 avr. 2021
publication
Functional heterogeneity of cytotoxic T cells and tumor resistance to cytotoxic hits limit anti-tumor activity in vivo.
Lire plus02 avr. 2021
26 mars 2021
publication
A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity.
Lire plus01 janv. 2021
publication
Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment.
Lire plus27 févr. 2017
publication
Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors
Lire plus14 sept. 2015
14 sept. 2015
11 mai 2015